November 20, 2014 10:22 PM ET

Biotechnology

Company Overview of Innovir Laboratories Inc., Prior to the reverse acquisition with VIMRx Pharmaceuticals Inc.

Company Overview

In December 1996, Innovir Laboratories, Inc. and VIMRx Pharmaceuticals, Inc. (VIMRx) consummated a transaction, whereby VIMRx acquired 68% of the outstanding stock of Innovir and Innovir acquired all of the issued and outstanding shares of VIMRx Holdings, Ltd. (VHL), a wholly owned subsidiary of VIMRx. The transaction resulted in a reverse acquisition, whereby VHL acquired Innovir. Prior to the acquisition, Innovir Laboratories, Inc., a biotechnology company, was engaged in developing a new class of therapeutic agents based on proprietary technology.

510 East 73rd Street

New York, NY 10021

United States

Founded in 1989

50 Employees

Phone:

212-249-4703

Key Executives for Innovir Laboratories Inc., Prior to the reverse acquisition with VIMRx Pharmaceuticals Inc.

Innovir Laboratories Inc., Prior to the reverse acquisition with VIMRx Pharmaceuticals Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
uBiome, Inc. United States
Angiorad, L.L.C. United States
Multigen Diagnostics, Inc. United States
Sutro Biopharma, Inc. United States
Twentyfirst Century Biochemicals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Innovir Laboratories Inc., Prior to the reverse acquisition with VIMRx Pharmaceuticals Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.